Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3469242
Reference Type
Journal Article
Title
Female exposure to phthalates and time to pregnancy: a first pregnancy planner study
Author(s)
Thomsen, AM; Riis, AH; Olsen, J; Jönsson, BA; Lindh, CH; Hjollund, NH; Jensen, TK; Bonde, JP; Toft, G
Year
2017
Is Peer Reviewed?
Yes
Journal
Human Reproduction
ISSN:
0268-1161
EISSN:
1460-2350
Publisher
Oxford University Press
Volume
32
Issue
1
Page Numbers
232-238
Language
English
PMID
27852689
DOI
10.1093/humrep/dew291
Web of Science Id
WOS:000394815100029
Abstract
STUDY QUESTION:
Is female exposure to phthalate metabolites associated with reduced fecundity, as estimated by prolonged time to pregnancy (TTP)?
SUMMARY ANSWER:
Female exposure to monoethyl phthalate (MEP) but not monobutyl phthalate (MBP), monobenzyl phthalate (MBzP) and monoethylhexyl phthalate (MEHP) was associated with a longer TTP.
WHAT IS KNOWN ALREADY:
Male exposure to phthalates is potentially associated with adverse effects on human fecundity in epidemiological studies, but little is known about the potential effects on female reproduction.
STUDY DESIGN SIZE AND DURATION:
A cohort study with prospective data based on 229 women from a Danish cohort of 430 first pregnancy planning couples enrolled in 1992-1994. In 2009, urinary analyses of phthalate metabolites were performed on stored urine samples from this cohort.
PARTICIPANTS/MATERIALS, SETTING AND METHODS:
We analyzed MEP, MBP, MBzP and MEHP in female morning spot urine samples collected daily during the first 10 days of menstrual cycles after discontinuation of contraception. The exposure assessment was based on the mean of two measurements from each woman collected in a period of 6 menstrual cycles. We used Cox regression with discrete time to estimate fecundability ratios (FRs) and 95% CI in relation to the average urine metabolite concentration exposure level, controlled for age and BMI, and the time-varying variables smoking and alcohol.
MAIN RESULT AND ROLE OF CHANCE:
Urinary concentration of MEP was associated with a decreased fecundity (adjusted FR 0.79; 95% CI: 0.63; 0.99) corresponding to a 21% decreased probability of conception for each natural log (ln) unit increase in MEP. No significant association with TTP was found for MBP, MBzP and MEHP.
LIMITATIONS REASONS FOR CAUTION:
Subfertile women were overrepresented in the study population due to exclusion of 77 high fertile women who became pregnant in the first cycle when urine collection began.
WIDER IMPLICATIONS OF THE FINDINGS:
Our results suggest that female exposure to MEP may have an adverse effect on female fecundity, but these findings need to be replicated in a larger and newer cohort study with sufficient exposure contrast if the use of diethyl phthalate (DEP) and thereby MEP in the future potentially should be regulated in cosmetics and industrial consumer products.
STUDY FUNDING/COMPETING INTERESTS:
The original data collected were founded by Aarhus University Research Foundation, the Danish Medical Research Council and the Danish Medical Health Insurance Foundation. There are no conflicts of interest to be declared.
TRIAL REGISTRATION NUMBER:
N/A.
Keywords
fertility; fecundity; time to pregnancy; MEP; phthalates
Tags
IRIS
•
Dibutyl Phthalate (DBP)
Database Searches
LitSearch Jan 2017 - July 2017
Pubmed
•
Diethyl phthalate (DEP)
Database searches
Jan 2017 update
Considered new
PubMed
Jul 2017 update
Web of Science
Jan 2020 update
PubMed
Web of Science
Primary source of health effects
Human health effects studies
•
Phthalates – Targeted Search for Epidemiological Studies
Source – all searches
Pubmed
WOS
Included
DEHP
DBP
BBP
DEP
Source - Dec 2016 Update (Private)
Pubmed
Source - August 2017 Update (Private)
Pubmed
WOS
Source - August 2018 Update
WOS
Toxline
Level 1 Screen - Title & Abstract
Included
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity